Dimensional Fund Advisors’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-225,919
| Closed | -$1.97M | – | 3459 |
|
|
2018
Q2 | $1.97M | Buy |
225,919
+76,614
| +51% | +$689K | ﹤0.01% | 2892 |
|
|
2018
Q1 | $1.51M | Buy |
149,305
+57,230
| +62% | +$481K | ﹤0.01% | 2921 |
|
|
2017
Q4 | $447K | Buy |
92,075
+5,209
| +6% | +$25.3K | ﹤0.01% | 3108 |
|
|
2017
Q3 | $395K | Buy |
86,866
+13,991
| +19% | +$65.7K | ﹤0.01% | 3136 |
|
|
2017
Q2 | $368K | Buy |
72,875
+1,344
| +2% | +$6.01K | ﹤0.01% | 3133 |
|
|
2017
Q1 | $340K | Hold |
71,531
| – | – | ﹤0.01% | 3148 |
|
|
2016
Q4 | $401K | Hold |
71,531
| – | – | ﹤0.01% | 3125 |
|
|
2016
Q3 | $397K | Sell |
71,531
-1,875
| -3% | -$12.4K | ﹤0.01% | 3095 |
|
|
2016
Q2 | $515K | Sell |
73,406
-7,367
| -9% | -$51.9K | ﹤0.01% | 3043 |
|
|
2016
Q1 | $534K | Sell |
80,773
-2,751
| -3% | -$20.2K | ﹤0.01% | 3035 |
|
|
2015
Q4 | $860K | Buy |
83,524
+21,572
| +35% | +$250K | ﹤0.01% | 2991 |
|
|
2015
Q3 | $730K | Buy |
61,952
+22,351
| +56% | +$247K | ﹤0.01% | 3054 |
|
|
2015
Q2 | $362K | Buy |
39,601
+8,463
| +27% | +$63.9K | ﹤0.01% | 3182 |
|
|
2015
Q1 | $193K | Buy |
31,138
+7,267
| +30% | +$45K | ﹤0.01% | 3235 |
|
|
2014
Q4 | $134K | Hold |
23,871
| – | – | ﹤0.01% | 3286 |
|
|
2014
Q3 | $141K | Hold |
23,871
| – | – | ﹤0.01% | 3295 |
|
|
2014
Q2 | $164K | Hold |
23,871
| – | – | ﹤0.01% | 3323 |
|
|
2014
Q1 | $172K | Hold |
23,871
| – | – | ﹤0.01% | 3322 |
|
|
2013
Q4 | $158K | Hold |
23,871
| – | – | ﹤0.01% | 3312 |
|
|
2013
Q3 | $174K | Buy |
+23,871
| New | +$161K | ﹤0.01% | 3332 |
|
Dimensional Fund Advisors's JNP Position: Q3 2018 in Review
Dimensional Fund Advisors sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 225,919 shares — an estimated $1.97M sold.
Dimensional Fund Advisors first reported a position in JNP in Q3 2013 and held it in 20 quarters. The position peaked at $1.97M in Q2 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.
- Dimensional Fund Advisors reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
- Dimensional Fund Advisors sold 225,919 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $1.97M.
- Dimensional Fund Advisors first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2013 and held it in 20 quarters.
- Dimensional Fund Advisors's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $1.97M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.
Based on Dimensional Fund Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.